Pemphigus is a potentially fatal autoimmune epidermal bullous disorder. Rituximab is a novel therapy for the treatment of refractory pemphigus. However, there is limited clinical data on safety and efficacy of rituximab in pediatric age group. Herein, we report an…
- Inicio
- Sobre nosotros
- Viviendo con P/P
- Investigación
- Involucrarse
- Noticias & Info
- Discussion Forums
